MOLECULAR DOCKING AND PHARMACOKINETIC EVALUATION OF NANOHERBAL SENDUDUK BULU (MICONIA CRENATA (VAHL) MICHELANG.) COMPOUNDS AS AKT1 INHIBITORS
DOI:
https://doi.org/10.22159/ijap.2025v17i2.52932Keywords:
AKT1 inhibition, Breast cancer, Insilico analysis, Miconia crenata, Molecular docking, NanoherbalAbstract
Objective: This study seeks to investigate the potential of 36 nanoherbal compounds extracted from senduduk bulu (Miconia crenata (Vahl) Michelang.) as inhibitors of v-akt murine thymoma viral oncogene homolog 1 (AKT1) using molecular docking techniques, pharmacokinetic analysis, safety evaluation, and bioactivity assessment.
Methods: Senduduk bulu leaves were nanoparticle-processed and analyzed via Gas Chromatography-Mass Spectrometry (GC-MS). Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) profiles and biological activities were predicted, and molecular docking assessed compound interactions with AKT1 using borussertib as a reference.
Results: Findings indicate that 20 out of 36 compounds meet the criteria as drug candidates, demonstrating favorable interactions with the AKT1 protein, although their affinity did not surpass that of the positive control, borussertib. Several compounds exhibited high oral bioavailability, showed no interaction with the liver enzyme Cytochrome P450 2D6 (CYP2D6), and did not inhibit the Organic cation transporter 2 (OCT2) protein in the kidneys. In terms of toxicity, these compounds displayed a range of effects, from non-hazardous to hazardous, with some potentially posing risks of hepatotoxicity, carcinogenicity, and mutagenicity.
Conclusion: This research highlights the potential of nanoherbal senduduk bulu in cancer therapy development; however, further validation through in vitro and in vivo studies is necessary to comprehensively ensure their efficacy and safety.
Downloads
References
Sung H, Ferley J, Siegel R, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. Ca Cancer J Clin [Internet]. 2021;71(3):209–49.
Grattagliano Z, Grattagliano A. Breast Cancer : The Road to a Personalized Prevention. igMin Res. 2024;2(3):163–70. Doi: 10.61927/igmin160
Tarannum J, Manaswini P, Deekshitha C, Gaju RK, Sunder AS. Reproductive Factors and Breast Cancer Risk. Int J Med Rev. 2019;6(2):40–4. Doi: 10.29252/IJMR-060203
Xu R chen, Zhang Y wu, Liu C cui, Xu Y ying, Shao Z ming, Yu K da. Series Immunotherapy and Its Racial Specificity for Breast Cancer Treatment in Asia : a Narrative Review. Lancet Reg Heal - West Pacifi [Internet]. 2024;1–13.
Wu P, Hu YZ. PI3K/Akt/mTOR Pathway Inhibitors in Cancer: A Perspective on Clinical Progress. Curr Med Chem. 2010;17(35):4326–41. Doi: 10.2174/092986710793361234
Joseph X, Akhil, Arathi, Megha KB, Vandana U, Mohanan. Toxicity Assessment of Nanoparticle. In: Biomedical Applications and Toxicity of Nanomaterials. Singapore: Springer Singapore; 2023. Doi: https://doi.org/10.1007/978-981-19-7834-0_16
Mahalekshmi V, Balakrishnan N, Ajay Kumar T V., Parthasarathy V. in Silico Molecular Screening and Docking Approaches on Antineoplastic Agent-Irinotecan Towards the Marker Proteins of Colon Cancer. Int J Appl Pharm. 2023;15(5):84–92. Doi: 10.22159/ijap.2023v15i5.48523
Fox EM, Kuba MG, Miller TW, Davies BR, Arteaga CL. Autocrine IGF-I/Insulin Receptor Axis Compensates for Inhibition of AKT in ER-Positive Breast Cancer Cells with Resistance to Estrogen Deprivation. Breast Cancer Res. 2013;15(4):1–14. Doi: 10.1186/bcr3449
Ohmoto A, Yachida S. Current Status of Poly(ADP-ribose) Polymerase Inhibitors and Future Directions. Onco Targets Ther. 2017;10(5):5195–208. Doi: 10.2147/OTT.S139336
Stanzione F, Giangreco I, Cole JC. Use of molecular docking computational tools in drug discovery [Internet]. 1st ed. Vol. 60, Progress in Medicinal Chemistry. Elsevier B.V.; 2021. 273–343 p. Doi: 10.1016/bs.pmch.2021.01.004
Carrella D, Manni I, Tumaini B, Dattilo R, Papaccio F, Mutarelli M, et al. Computational Drugs Repositioning Identifies Inhibitors of Oncogenic PI3K/AKT/P70S6K-Dependent Pathways Among FDA-Approved Compounds. Oncotarget [Internet]. 2016;7(37).
Mursal M, Ahmad M, Hussain S, Faraz Khan M. Navigating the Computational Seas: A Comprehensive Overview of Molecular Docking Software in Drug Discovery. Unravelling Mol Docking - From Theory to Pract [Working Title]. 2024; Doi: 10.5772/intechopen.1004802
Chaudhary M, Tyagi K. A Review on Molecular Docking and Its Application. Int J Adv Res. 2024;12(03):1141–53. Doi: 10.21474/ijar01/18505
Bajpai P, Usmani S, Kumar R, Prakash O. Recent Advances in Anticancer Approach of Traditional Medicinal Plants: A novel Strategy for Cancer Chemotherapy. Intell Pharm. 2024;2(3):291–304. Doi: 10.1016/j.ipha.2024.02.001
Tuginah, Samitra D, Lokaria E. Pengaruh Air Rebusan Daun Harendong Bulu (Clidemia hirta) Terhadap Kadar Kolestrol Mencit (Mus musculus). J Biosilampari J Biol. 2020;3(1):1–6. Doi: 10.31540/biosilampari.v3i1.972
Petrovic S, Bita B, Barbinta-Patrascu ME. Nanoformulations in Pharmaceutical and Biomedical Applications: Green Perspectives. Int J Mol Sci. 2024;25(11). Doi: 10.3390/ijms25115842
Gophane SR, Jadhao SR, Jamdhade PB. Bergenia Ciliata: Isolation of Active Flavonoids, Gc-Ms Analysis, Adme Study and Inhibition Activity of Oxalate Synthesizing Enzymes. Int J Pharm Pharm Sci. 2021;13(11):34–46. Doi: 10.22159/ijpps.2021v13i11.42127
Santoso P, Ilyas S, Midoen YH, Maliza R, Belahusna DF. Predictive bioactivity of compounds from Vitis gracilis leaf extract to counteract doxorubicin-induced cardiotoxicity via sirtuin 1 and adenosine monophosphate-activated protein kinase: An in-silico study. J Appl Pharm Sci. 2024;14(4):99–114. Doi: 10.7324/JAPS.2024.167007
Alam N, Banu N, Aziz MAI, Barua N, Ruman U, Jahan I, et al. Chemical Profiling, Pharmacological Insights and In Silico Studies of Methanol Seed Extract of Sterculia foetida. Plants. 2021;10(6). Doi: 10.3390/plants10061135
Satya MS, Suma B V, Aiswariya. Molecular Docking and Admet Studies of Ethanone, 1-(2-Hydroxy-5-Methyl Phenyl) for Anti-Microbial Properties. Int J Pharm Pharm Sci. 2022;14(6):24–7. Doi: 10.22159/ijpps.2022v14i6.44548
Shuttleworth A, Johnson SD. GC-MS/FID/EAD: A Method for Combining Mass Spectrometry with Gas Chromatography-Electroantennographic Detection. Front Ecol Evol. 2022;10(December):1–10. Doi: 10.3389/fevo.2022.1042732
Oliver Fiehn. Metabolomics by Gas Chromatography-Mass Spectrometry: The Combination of Targeted and Untargeted Profiling [Internet]. Vol. 7, Curr Protoc Mol Biol. 2017. 232–235 p. Doi: 10.1002/0471142727.mb3004s114.Metabolomics
Gomathi D, Kalaiselvi M, Ravikumar G, Devaki K, Uma C. GC-MS Analysis of Bioactive Compounds from The Whole Plant Ethanolic Extract of Evolvulus alsinoides (L.) L. J Food Sci Technol. 2015;52(2):1212–7. Doi: 10.1007/s13197-013-1105-9
Masera K, Hossain AK, Davies PA, Doudin K. Investigation of 2-Butoxyethanol as Biodiesel Additive on Fuel Property and Combustion Characteristics of Two Neat Biodiesels. Renew Energy. 2021;164:285–97. Doi: 10.1016/j.renene.2020.09.064
Ahmed MU, Arise RO, Umaru IJ, Mohammed A. Antidiarheal Activity of Catechol and Ethyl 5, 8,11,14,17- Icosapentanoate-Rich Fraction of Annona senegalensis Stem Bark. J Tradit Complement Med. 2022;12(2):190–4. Doi: 10.1016/j.jtcme.2021.07.007
Aljazy NAS. Antioxidant Activity and The Laxative Agent of Red Hawthorn (Crataegus sumbollis) in Jam Industry. J Surv Fish Sci [Internet]. 2023;10(2).
Bitew M, Desalegn T, Demissie TB, Belayneh A, Endale M, Eswaramoorthy R. Pharmacokinetics and Drug-likeness of Antidiabetic Flavonoids: Molecular Docking and DFT Study. PLoS One. 2021;16(12 December). Doi: 10.1371/journal.pone.0260853
Alqahtani MS, Kazi M, Alsenaidy MA, Ahmad MZ. Advances in Oral Drug Delivery. Front Pharmacol. 2021;12(February). Doi: 10.3389/fphar.2021.618411
Kumari L, Choudhari Y, Patel P, Gupta G Das, Singh D, Rosenholm JM, et al. Advancement in Solubilization Approaches: A Step towards Bioavailability Enhancement of Poorly Soluble Drugs. Life. 2023;13(5). Doi: 10.3390/life13051099
Mendie LE, Hemalatha S. Molecular Docking of Phytochemicals Targeting GFRs as Therapeutic Sites for Cancer: an In Silico Study. Appl Biochem Biotechnol. 2022;194(1):215–31. Doi: 10.1007/s12010-021-03791-7
Durán-Iturbide NA, Díaz-Eufracio BI, Medina-Franco JL. In Silico ADME/Tox Profiling of Natural Products: A Focus on BIOFACQUIM. ACS Omega. 2020;5(26):16076–84. Doi: 10.1021/acsomega.0c01581
Azman M, Sabri AH, Anjani QK, Mustaffa MF, Hamid KA. Intestinal Absorption Study: Challenges and Absorption Enhancement Strategies in Improving Oral Drug Delivery. Pharmaceuticals. 2022;15(8):1–24. Doi: 10.3390/ph15080975
Lennernäs H. Regional Intestinal Drug Permeation: Biopharmaceutics and Drug Development. Eur J Pharm Sci. 2014;57(1):333–41. Doi: 10.1016/j.ejps.2013.08.025
Artursson P, Karlsson J. Correlation Between Oral Drug Absorption in Humans and Apparent Drug Permeability Coefficiens in Human Intestinal Epithelial (Caco-2) Cell. Biochem Biophys Res Commun [Internet]. 1991;175(3):880–5.
Sawant-Basak A, Rodrigues AD, Lech M, Doyonnas R, Kasaian M, Prasad B, et al. Physiologically Relevant, Humanized Intestinal Systems to Study Metabolism and Transport of Small Molecule Therapeutics. Drug Metab Dispos. 2018;46(11):1581–7. Doi: 10.1124/dmd.118.082784
Teleanu RI, Preda MD, Niculescu AG, Vladâcenco O, Radu CI, Grumezescu AM, et al. Current Strategies to Enhance Delivery of Drugs across the Blood–Brain Barrier. Pharmaceutics. 2022;14(5):1–30. Doi: 10.3390/pharmaceutics14050987
Wang D, Poi MJ, Sun X, Gaedigk A, Leeder JS, Sadee W. Common CYP2D6 Polymorphisms Affecting Alternative Splicing and Transcription: Long-range Haplotypes with Two Regulatory Variants modulate CYP2D6 activity. Hum Mol Genet. 2014;23(1):268–78. Doi: 10.1093/hmg/ddt417
Zanger UM, Schwab M. Regulation of Gene Expression, Enzyme Activities, and Impact of Genetic Variation. Pharmacol Ther. 2013;138(1):103–41. Doi: 10.1016/j.pharmthera.2012.12.007
Koepsell H. Update on Drug-Drug Interaction at Organic Cation Transporters: Mechanisms, Clinical Impact, and Proposal for Advanced In Vitro Testing. Expert Opin Drug Metab Toxicol. 2021;17(6):635–53. Doi: 10.1080/17425255.2021.1915284
Łapczuk-Romańska J, Droździk M, Oswald S, Droździk M. Kidney Drug Transporters in Pharmacotherapy. Int J Mol Sci. 2023;24(3):1–17. Doi: 10.3390/ijms24032856
Nies AT, Koepsell H, Damme K, Schwab M. Organic Cation Tranporters (OCTs, MATEs), In Vitro and In Vivo Evidance for the Importance In Drug Therapy. Berlin: Springer Berlin Heidelberg; 2011. Doi: https://doi.org/10.1007/978-3-642-14541-4_3
Savjani KT, Gajjar AK, Savjani JK. Drug Solubility: Importance and Enhancement Techniques. ISRN Pharm. 2012;2012(100 mL):1–10. Doi: 10.5402/2012/195727
Munnangi SR, Youssef AAA, Narala N, Lakkala P, Narala S, Vemula SK, et al. Drug Complexes: Perspective from Academic Research and Pharmaceutical Market. Pharm Res. 2023;40(6):1519–40. Doi: 10.1007/s11095-023-03517-w
Rahman M, Rahaman S, Islam R, Rahman F, Mithi FM, Alqahtani T, et al. Role of Phenolic Compounds in Human Disease : Current. Molecules [Internet]. 2022;27(233):1–36.
Lee Y, Park HG, Kim V, Cho MA, Kim H, Ho TH, et al. Inhibitory Effect of α-terpinyl acetate on Cytochrome P450 2B6 Enzymatic Activity. Chem Biol Interact. 2018;289:90–7. Doi: 10.1016/j.cbi.2018.04.029
Sørli JB, Frederiksen M, Nikolov NG, Wedebye EB, Hadrup N. Identification of Substances with a Carcinogenic Potential in Spray-Formulated Engine/Brake Cleaners and Lubricating Products, Available in the European Union (EU)–based on IARC and EU-Harmonised Classifications and QSAR Predictions. Toxicology. 2022;477:153261. Doi: 10.1016/j.tox.2022.153261
Melekhina VG, Mityanov VS, Komogortsev AN, Lichitski B V., Dudinov AA, Shirinian VZ, et al. Condensation of 5-hydroxy-2-methyl-4H-pyran-4-one with arylglyoxals. Synthesis and properties of 2-aryl-1-(3-hydroxy-6-methyl-4-oxo-4H-pyran-2-yl)ethane-1,2-diones. Russ Chem Bull. 2018;67(10):1873–7. Doi: 10.1007/s11172-018-2301-6
Infanger D, Schmidt-Trucksäss A. P Value Functions: An Underused Method to Present Research Results and to Promote Quantitative Reasoning. Stat Med. 2019;38(21):4189–97. Doi: 10.1002/sim.8293
Jin W. Metastasis, The Transition of Cancer Stem Cells, and Chemoresistance of Cancer by Epithelial-Mesenchymal Transition. Mdpi [Internet]. 2020;9(217):1–23.
Rehman B, Abubakar M, Kiani MN, Ayyoub R. Analysis of Genetic Alterations in TP53 Gene in Breast Cancer. Proc Anticancer Res [Internet]. 2024;8(3):25–35.
Moawadh MS. Molecular Docking Analysis of Natural Compounds as TNF-α Inhibitors for Crohn’s Disease Management. Bioinformation. 2023;19(6):716–20. Doi: 10.6026/97320630019716
Landel I, Reintjes C, Uhlenbrock N, Trajkovic-arsic M, Dienstbier N, Hardick J, et al. Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination with Trametinib in KRAS -Mutant Pancreatic and Colorectal Cancer. Transl Sci. 2019;79(9):2367–78. Doi: 10.1158/0008-5472.CAN-18-2861
Zhong HA, Goodwin DT. Selectivity Studies and Free Energy Calculations of AKT Inhibitors. Molecules. 2024;29(6). Doi: 10.3390/molecules29061233
Zhang Y, Zhang C, Li J, Jiang M, Guo S, Yang G, et al. Inhibition of AKT Induces p53/SIRT6/PARP1-dependent Parthanatos to Suppress Tumor Growth. Cell Commun Signal. 2022;20(1):1–21. Doi: 10.1186/s12964-022-00897-1
Rehan M, Beg MA, Parveen S, Damanhouri GA, Zaher GF. Computational Insights into the Inhibitory Mechanism of Human AKT1 by an Orally Active Inhibitor, MK-2206. PLoS One. 2014;9(10):18–22. Doi: 10.1371/journal.pone.0109705
Published
How to Cite
Issue
Section
Copyright (c) 2024 DINA KHAIRANI, SYAFRUDDIN ILYAS, DINI PRASTYO WATI
This work is licensed under a Creative Commons Attribution 4.0 International License.
